As of Apr 20
| -0.53 / -0.17%|
The 9 analysts offering 12-month price forecasts for Abiomed Inc have a median target of 300.00, with a high estimate of 370.00 and a low estimate of 259.00. The median estimate represents a -1.94% decrease from the last price of 305.92.
The current consensus among 12 polled investment analysts is to Buy stock in Abiomed Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.